Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for IDEXX Laboratories, Inc. (IDXX : NSDQ)

• Company Description    IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Number of Employees: 11,000

• Price / Volume Information    Yesterday's Closing Price: $634.36 Daily Weekly Monthly 20 Day Moving Average: 409,073 shares Shares Outstanding: 80.00 (millions) Market Capitalization: $50,751.77 (millions) Beta: 1.58 52 Week High: $688.12 52 Week Low: $356.14 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.71% -3.63% 12 Week -1.18% -9.67% Year To Date 53.44% 30.96%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL ONE IDEXX DRIVE - WESTBROOK,ME 04092 USA ph: 207-556-0300 fax: 207-556-4346 investorrelations@idexx.com http://www.idexx.com

• General Corporate Information    Officers Jonathan J. Mazelsky - President; Chief Executive Officer and Director Lawrence D. Kingsley - Chairman Brian P. McKeon - Executive Vice President; Chief Financial Officer Irene Chang Britt - Director Bruce L. Claflin - Director Peer Information IDEXX Laboratories, Inc. (ABMD) IDEXX Laboratories, Inc. (DMDS) IDEXX Laboratories, Inc. (CPWY.) IDEXX Laboratories, Inc. (EQUR) IDEXX Laboratories, Inc. (ECIA) IDEXX Laboratories, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 45168D104 SIC: 2835 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/03/25 Share - Related Items Shares Outstanding: 80.00 Most Recent Split Date: 6.00 (2.00:1) Beta: 1.58 Market Capitalization: $50,751.77 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $2.88 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $12.61 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 12.25% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/03/25

• Fundamental Ratios P/E Current FY Estimate: 50.31 Trailing 12 Months: 52.82 PEG Ratio: 4.11 Price Ratios Price/Book: 34.79 Price/Cash Flow: 51.04 Price / Sales: 12.57 EPS Growth vs. Year Ago Period: 48.77% vs. Previous Quarter: 22.64% Sales Growth vs. Year Ago Period: 10.55% vs. Previous Quarter: 11.12% ROE 09/30/25 - - 06/30/25 - 64.42 03/31/25 - 57.35 ROA 09/30/25 - - 06/30/25 - 29.89 03/31/25 - 26.97 Current Ratio 09/30/25 - - 06/30/25 - 1.11 03/31/25 - 1.16 Quick Ratio 09/30/25 - - 06/30/25 - 0.79 03/31/25 - 0.81 Operating Margin 09/30/25 - - 06/30/25 - 24.41 03/31/25 - 22.76 Net Margin 09/30/25 - - 06/30/25 - 24.41 03/31/25 - 22.76 Pre-Tax Margin 09/30/25 - - 06/30/25 - 30.41 03/31/25 - 28.60 Book Value 09/30/25 - - 06/30/25 - 18.23 03/31/25 - 18.00 Inventory Turnover 09/30/25 - - 06/30/25 - 3.98 03/31/25 - 3.94 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.31 03/31/25 - 0.31 Debt-to-Capital 09/30/25 - - 06/30/25 - 23.57 03/31/25 - 23.70

Powered by Zacks Investment Research ©